2023 Guideline for the management of patients with aneurysmal subarachnoid hemorrhage: a guideline from the American Heart Association/American Stroke …

BL Hoh, NU Ko, S Amin-Hanjani, SHY Chou… - Stroke, 2023 - Am Heart Assoc
Aim: The “2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid
Hemorrhage” replaces the 2012 “Guidelines for the Management of Aneurysmal …

A review of the management of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

K Li, CD Barras, RV Chandra, HK Kok, JT Maingard… - World neurosurgery, 2019 - Elsevier
Background Despite decades of research, cerebral vasospasm (CV) continues to account
for high morbidity and mortality in patients who survive their initial aneurysmal subarachnoid …

Prophylactic therapies for morbidity and mortality after aneurysmal subarachnoid hemorrhage: a systematic review and network meta-analysis of randomized trials

M Dayyani, B Sadeghirad, JC Grotta, S Zabihyan… - Stroke, 2022 - Am Heart Assoc
Background: Aneurysmal subarachnoid hemorrhage (aSAH) is associated with high
mortality and morbidity. We aimed to determine the relative benefits of pharmacological …

[HTML][HTML] Korean clinical practice guidelines for aneurysmal subarachnoid hemorrhage

WS Cho, JE Kim, SQ Park, JK Ko… - Journal of Korean …, 2018 - synapse.koreamed.org
Despite advancements in treating ruptured cerebral aneurysms, an aneurysmal
subarachnoid hemorrhage (aSAH) is still a grave cerebrovascular disease associated with a …

Intracerebral hemorrhage location and functional outcomes of patients: a systematic literature review and meta-analysis

A Sreekrishnan, JL Dearborn, DM Greer, FD Shi… - Neurocritical care, 2016 - Springer
Abstract Background and Purpose Intracerebral hemorrhage (ICH) has the highest mortality
rate among all strokes. While ICH location, lobar versus non-lobar, has been established as …

Pharmacological prevention of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage

MM Caylor, RL Macdonald - Neurocritical Care, 2024 - Springer
Background Causes of morbidity and mortality following aneurysmal subarachnoid
hemorrhage (aSAH) include early brain injury and delayed neurologic deterioration, which …

[HTML][HTML] Serum concentration–guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: A …

C Wipplinger, A Cattaneo, TM Wipplinger… - Neurosurgical …, 2023 - Springer
Delayed cerebral infarction (DCI) is a major cause of morbidity and mortality in patients with
aneurysmal subarachnoid hemorrhage (aSAH). The benefits of magnesium sulfate as an …

Vasospasm in cerebral inflammation

M Eisenhut - International journal of inflammation, 2014 - Wiley Online Library
All forms of cerebral inflammation as found in bacterial meningitis, cerebral malaria, brain
injury, and subarachnoid haemorrhage have been associated with vasospasm of cerebral …

Direct Anterior Approach Versus Posterolateral Approach in Total Hip Arthroplasty: A Systematic Review and Meta‐analysis of Randomized Controlled Studies

X Yang, H Huang, L Sun, Z Yang, C Deng… - Orthopaedic …, 2020 - Wiley Online Library
Objective To compare the early rehabilitation effects of total hip arthroplasty (THA) with the
direct anterior approach (DAA) versus the posterior approach (PA). Methods We searched …

Treatment of magnesium-L-threonate elevates the magnesium level in the cerebrospinal fluid and attenuates motor deficits and dopamine neuron loss in a mouse …

Y Shen, L Dai, H Tian, R Xu, F Li, Z Li… - Neuropsychiatric …, 2019 - Taylor & Francis
Purpose Epidemiology research has demonstrated that magnesium (Mg) deficiency is
associated with a high incidence of Parkinson's disease (PD). It is known that the systemic …